Multilayered molecular profiling supported the monoclonal origin of metastatic renal cell carcinoma

International Journal of Cancer

Volumn 135, Issue 1, 2014, Pages 78-87

  Huang, Yi ^a,b   Gao, Shengjie ^c   Wu, Song ^a,b,d   Song, Pengfei ^c   Sun, Xiaojuan ^a,b   Hu, Xueda ^c   Zhang, Shiqiang ^e   Yu, Yuan ^c   Zhu, Jialou ^c   Li, Cailing ^e   Qin, Zike ^d   Xie, Liangfu ^e   Yao, Qiong ^c   Tang, Aifa ^a,b   Li, Zesong ^a,b   Guo, Guangwu ^c   Wan, Shengqing ^c   Dong, Pei ^d   Sun, Liang ^a   Li, Weiping ^a   Wang, Daping ^a   Gui, Yaoting ^e   Yang, Huanming ^c   Zhou, Fangjian ^d   Zhang, Xiuqing ^c   Cai, Zhiming ^a,b   more..

^a THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^b National Regional Key Technology Engineering Laboratory for Medical Ultrasound   (China)

^c BGI SHENZHEN   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^e PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

metastasis; renal cancer; tumor evolution

Indexed keywords

METASTASIS; RENAL CANCER; TUMOR EVOLUTION;

BRAIN NEOPLASMS; CARCINOGENESIS; CARCINOMA, RENAL CELL; EXOME; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84899428170     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28654     Document Type: Article

References (31)

1. Chaffer CL, Weinberg RA,. A perspective on cancer cell metastasis. Science 2011; 331: 1559-64.
2. Lam JS, Shvarts O, Leppert JT, et al. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005; 173: 1853-62.
3. Xu X, Hou Y, Yin X, et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 2012; 148: 886-95.
4. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-92.
5. Wu C, Wyatt AW, Lapuk AV, et al. Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer. J Pathol 2012; 227: 53-61.
6. Nik-Zainal S, Van Loo P, Wedge DC, et al. The life history of 21 breast cancers. Cell 2012; 149: 994-1007.
7. Li H, Durbin R,. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-60.
8. Campbell PJ, Stephens PJ, Pleasance ED, et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 2008; 40: 722-9.
9. Venkatraman ES, Olshen AB,. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007; 23: 657-63.
10. Gui Y, Guo G, Huang Y, et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 2011; 43: 875-8.
11. Wang L, Sun J, Wu H, et al. Systematic assessment of reduced representation bisulfite sequencing to human blood samples: A promising method for large-sample-scale epigenomic studies. J Biotechnol 2012; 157: 1-6.
12. Ren S, Peng Z, Mao JH, et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 2012; 22: 806-21.
13. Guo G, Gui Y, Gao S, et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet 2012; 44: 17-9.
14. Jones S, Chen WD, Parmigiani G, et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A 2008; 105: 4283-8.
15. Rabes HM, Carl P, Meister P, et al. Analysis of proliferative compartments in human tumors. I. Renal adenocarcinoma. Cancer 1979; 44: 799-813.
16. Djordjevic G, Mozetic V, Mozetic DV, et al. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma. Pathol Res Pract 2007; 203: 99-106.
17. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114-7.
18. Osunkoya AO, Yin-Goen Q, Phan JH, et al. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis. Hum Pathol 2009; 40: 1671-8.
19. Lubensky IA, Gnarra JR, Bertheau P, et al. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol 1996; 149: 2089-94.
20. Gronwald J, Storkel S, Holtgreve-Grez H, et al. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res 1997; 57: 481-7.
21. Bissig H, Richter J, Desper R, et al. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. Am J Pathol 1999; 155: 267-74.
22. Nodin B, Fridberg M, Uhlen M, et al. Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer. J Ovarian Res 2012; 5: 6.
23. Varela I, Tarpey P, Raine K, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011; 469: 539-42.
24. Philp AJ, Campbell IG, Leet C, et al. The phosphatidylinositol 3′-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 2001; 61: 7426-9.
25. Urick ME, Rudd ML, Godwin AK, et al. PIK3R1 (p85alpha) is somatically mutated at high frequency in primary endometrial cancer. Cancer Res 2011; 71: 4061-7.
26. Siegmund KD, Marjoram P, Woo YJ, et al. Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers. Proc Natl Acad Sci U S A 2009; 106: 4828-33.
27. Ramaswamy S, Ross KN, Lander ES, et al. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49-54.
28. Jones J, Otu H, Spentzos D, et al. Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 2005; 11: 5730-9.
29. Huang da W, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
30. Klatte T, Seligson DB, Riggs SB, et al. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin Cancer Res 2007; 13: 7388-93.
31. Fisher R, Larkin J, Swanton C,. Inter and intratumour heterogeneity: a barrier to individualized medical therapy in renal cell carcinoma? Front Oncol 2012; 2: 49.